Cargando…

Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis

BACKGROUND: Vaccination can have an impact on menstruation, and this impact may be more notable in women with inflammatory gynecological pathologies such as endometriosis. OBJECTIVES: We aimed to investigate the impact of mRNA-based SARS-CoV-2 vaccines on menstrual cycle–related symptoms in women wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Zamora, María Ángeles, Feixas, Georgina, Gracia, Meritxell, Rius, Mariona, Quintas, Lara, de Guirior, Cristian, Carmona, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251079/
https://www.ncbi.nlm.nih.gov/pubmed/37282979
http://dx.doi.org/10.1177/17455057231176751
_version_ 1785055875735486464
author Martínez-Zamora, María Ángeles
Feixas, Georgina
Gracia, Meritxell
Rius, Mariona
Quintas, Lara
de Guirior, Cristian
Carmona, Francisco
author_facet Martínez-Zamora, María Ángeles
Feixas, Georgina
Gracia, Meritxell
Rius, Mariona
Quintas, Lara
de Guirior, Cristian
Carmona, Francisco
author_sort Martínez-Zamora, María Ángeles
collection PubMed
description BACKGROUND: Vaccination can have an impact on menstruation, and this impact may be more notable in women with inflammatory gynecological pathologies such as endometriosis. OBJECTIVES: We aimed to investigate the impact of mRNA-based SARS-CoV-2 vaccines on menstrual cycle–related symptoms in women with endometriosis and assess the effect of hormonal therapy on potential SARS-CoV-2 vaccination-induced menstrual changes. DESIGN: A total of 848 women who received at least two doses of mRNA-based COVID-19 vaccines were prospectively recruited: 407 with endometriosis (endometriosis group) and 441 healthy controls (non-endometriosis group). METHODS: Data regarding demographics, clinical characteristics, hormonal treatment, and menstrual-associated symptoms in the first and second cycle after vaccination were collected through an online survey. RESULTS: A similar percentage of patients in both the endometriosis and the non-endometriosis group self-reported menstrual-associated changes the first (52.6% versus 48.8%, respectively) and second cycle after vaccination (29.0% versus 28.1%, respectively). Although the total symptoms recorded were not different between the two groups, several specific symptoms were statistically more frequent in the endometriosis group. These were pain disorders and fatigue in the first cycle after vaccination and pain disorders, menstrual headache and fatigue in the second cycle after vaccination. Bleeding frequency/regularity disorders were found to be more frequent in the non-endometriosis group in the first cycle after vaccination. Patients under hormonal treatment reported fewer changes in menstrual symptoms in the first and second cycle after vaccination compared with those not receiving this treatment. Similarly, patients in the endometriosis group receiving hormonal treatment reported fewer changes in menstrual-associated symptoms compared with those not following any hormonal treatment in the first and second menstrual cycle after the last vaccination. CONCLUSION: Women with endometriosis immunized with mRNA-based SARS-CoV-2 vaccines did not perceive greater worsening or new menstrual-associated symptoms after complete COVID-19 vaccination compared with healthy controls. Hormonal treatment may have a protective effect against worsened or new menstrual symptoms induced by COVID-19 vaccination.
format Online
Article
Text
id pubmed-10251079
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102510792023-06-09 Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis Martínez-Zamora, María Ángeles Feixas, Georgina Gracia, Meritxell Rius, Mariona Quintas, Lara de Guirior, Cristian Carmona, Francisco Womens Health (Lond) Original Research Article BACKGROUND: Vaccination can have an impact on menstruation, and this impact may be more notable in women with inflammatory gynecological pathologies such as endometriosis. OBJECTIVES: We aimed to investigate the impact of mRNA-based SARS-CoV-2 vaccines on menstrual cycle–related symptoms in women with endometriosis and assess the effect of hormonal therapy on potential SARS-CoV-2 vaccination-induced menstrual changes. DESIGN: A total of 848 women who received at least two doses of mRNA-based COVID-19 vaccines were prospectively recruited: 407 with endometriosis (endometriosis group) and 441 healthy controls (non-endometriosis group). METHODS: Data regarding demographics, clinical characteristics, hormonal treatment, and menstrual-associated symptoms in the first and second cycle after vaccination were collected through an online survey. RESULTS: A similar percentage of patients in both the endometriosis and the non-endometriosis group self-reported menstrual-associated changes the first (52.6% versus 48.8%, respectively) and second cycle after vaccination (29.0% versus 28.1%, respectively). Although the total symptoms recorded were not different between the two groups, several specific symptoms were statistically more frequent in the endometriosis group. These were pain disorders and fatigue in the first cycle after vaccination and pain disorders, menstrual headache and fatigue in the second cycle after vaccination. Bleeding frequency/regularity disorders were found to be more frequent in the non-endometriosis group in the first cycle after vaccination. Patients under hormonal treatment reported fewer changes in menstrual symptoms in the first and second cycle after vaccination compared with those not receiving this treatment. Similarly, patients in the endometriosis group receiving hormonal treatment reported fewer changes in menstrual-associated symptoms compared with those not following any hormonal treatment in the first and second menstrual cycle after the last vaccination. CONCLUSION: Women with endometriosis immunized with mRNA-based SARS-CoV-2 vaccines did not perceive greater worsening or new menstrual-associated symptoms after complete COVID-19 vaccination compared with healthy controls. Hormonal treatment may have a protective effect against worsened or new menstrual symptoms induced by COVID-19 vaccination. SAGE Publications 2023-06-07 /pmc/articles/PMC10251079/ /pubmed/37282979 http://dx.doi.org/10.1177/17455057231176751 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Martínez-Zamora, María Ángeles
Feixas, Georgina
Gracia, Meritxell
Rius, Mariona
Quintas, Lara
de Guirior, Cristian
Carmona, Francisco
Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title_full Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title_fullStr Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title_full_unstemmed Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title_short Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis
title_sort evaluation of menstrual symptoms after coronavirus disease 2019 vaccination in women with endometriosis
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251079/
https://www.ncbi.nlm.nih.gov/pubmed/37282979
http://dx.doi.org/10.1177/17455057231176751
work_keys_str_mv AT martinezzamoramariaangeles evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT feixasgeorgina evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT graciameritxell evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT riusmariona evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT quintaslara evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT deguiriorcristian evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis
AT carmonafrancisco evaluationofmenstrualsymptomsaftercoronavirusdisease2019vaccinationinwomenwithendometriosis